After doing some research, I found that the export of levetiracetam has increased by 10% YoY in July and 20% YoY in august. I couldnt find the company wise break-up from exim website. But it looks plausible that company reports good growth in its Q2 figures and that is being discounted by the markets.
If someone has more details on export no.s, please share the same. I am also trying to do further research into it.
Subscribe To Our Free Newsletter |